Canada markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.11+0.33 (+2.23%)
As of 2:48PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close14.78
Open14.81
Bid15.10 x 1200
Ask15.12 x 900
Day's Range14.80 - 15.24
52 Week Range9.53 - 70.29
Volume528,075
Avg. Volume4,559,787
Market Cap1.054B
Beta (5Y Monthly)1.44
PE Ratio (TTM)N/A
EPS (TTM)-0.94
Earnings DateAug. 09, 2021 - Aug. 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.29
  • ChemoCentryx to Hold Second Quarter 2021 Financial Results Conference Call on Monday, August 9, 2021
    GlobeNewswire

    ChemoCentryx to Hold Second Quarter 2021 Financial Results Conference Call on Monday, August 9, 2021

    MOUNTAIN VIEW, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2021 financial results will be released after market close on Monday, August 9, 2021. ChemoCentryx executive management will host a conference call and webcast beginning at 5:00 p.m. Eastern Time on August 9, 2021 to discuss these results and to answer questions. To participate by telephone, please dial (877) 303-8028 (Domestic) or (760) 536-5167 (Interna

  • 2 Beaten-Down Biotech Stocks That Could Bounce Back
    Motley Fool

    2 Beaten-Down Biotech Stocks That Could Bounce Back

    The market hasn't been kind to these two drugmakers, but both have a chance to turn things around.

  • Is Now the Time to Buy ChemoCentryx Stock?
    Motley Fool

    Is Now the Time to Buy ChemoCentryx Stock?

    Shares of the highly popular biotech stock ChemoCentryx (NASDAQ: CCXI) ticked up a few notches after a Wall Street analyst upgraded the stock to buy. Stifel analyst Dae Gon Ha thinks a recent development regarding the clinical-stage biotech's lead candidate is a pretty big deal that the rest of the stock market has mostly overlooked. Does recent receptivity from the Food and Drug Administration make ChemoCentryx a good stock to buy now, or is there another heartbreak on the horizon?